CVS Group
Website:
CVS Group
Index:
AIM
EPIC: CVSG
Supersector:
Retail
Sector:
General Retailers
Subsector:
Specialized Consumer Services
Market Cap:
£873.55M
Payout Frequency: Annual
CVS Group Dividend Analysis and Summary
Dividend Details
- Declared: Final dividend of 8.5p per share (FY24: 8.0p, +6.3%)
- Policy: Board reiterates a progressive dividend policy
- Ex-dividend date: 06/11/2025
- Record date: 07/11/2025
- Payment date: 05/12/2025
- Approval: Subject to shareholder approval at the AGM on 18/11/2025
- Indicative yield: c.0.7% on the year-end share price of 1,250p (final dividend only)
Payout Capacity and Coverage
- Adjusted EPS: 80.1p; final dividend cover c.9.4x
- Free cash flow (FY25): £72.2m; estimated cash cost of final dividend c.£6.1m (c.12x FCF cover)
- Adjusted operating cash conversion: 76.9% (vs 70.1% FY24)
- Leverage: 1.18x (bank test), well below the <2.0x target ceiling; facilities of £350m to Feb 2028 with ample headroom
Context and Notable Items
- Revenue: £673.2m (+5.4%); Adjusted EBITDA: £134.6m (+9.4%), margin 20.0%
- Statutory profit boosted by the sale of Crematoria; core PBT down on higher finance and depreciation costs
- Like-for-like sales: Group +0.2% (Practices +1.0%) with stronger Q4 momentum
- Capital allocation: Ongoing capex (£33.2m continuing ops) and Australia M&A (£29.2m in FY25; further £23.6m post year-end)
Structural Changes / Events Affecting Dividend Outlook
- Divestment of UK Crematoria for £42.3m (10x adj. EBITDA), strengthening the balance sheet and funding expansion
- Inorganic growth continues in Australia, including deals with non-controlling interests (70%/75% stakes), modestly reducing attributable cash inflows to the Group
- CMA market investigation in the UK ongoing; provisional decision expected mid-October 2025 with potential remedies (e.g., joint branding, standardised price lists)
Assessment for Dividend-Focused Investors
- Sustainability: Very strong based on low payout, robust FCF, improved cash conversion, and low leverage. Interest cover remains healthy and facilities extend to 2028.
- Growth trajectory: Final DPS up 6.3%; management reiterates a progressive policy. With consensus FY26 adjusted EBITDA around £141m, capacity for continued DPS growth looks intact, assuming stable trading and ongoing cash generation.
- Support from financials and capital allocation: Dividend is clearly a secondary but reliable use of cash after disciplined capex (c.£30–50m p.a.) and acquisitions (~£50m p.a. subject to timing), consistent with a growth-first strategy and leverage cap at <2.0x.
Risks and Flags to Dividend Stability
- CMA outcome risk: Remedies could pressure UK pricing, disclosure and margins; heightened sector scrutiny may weigh on growth and sentiment.
- Cost inflation: UK wage and Employers’ NI increases (annualised c.£11m) may compress margins if not offset by efficiencies and price/mix.
- Operational soft spots: Laboratories lost a major customer; online retail declined; UK LFLs modest. Execution on efficiency and Australia expansion key.
- RDEC dependence: Research & Development Expenditure Credit of £15.1m materially supports EBITDA; changes to RDEC could affect reported profitability and cash.
- FX/structure: Expanded Australia footprint introduces FX translation volatility and NCI leakage, though balance sheet strength mitigates.
Read more
CVS Group Annual Dividend Yield - 0%
Dividends Used in Calculation:
| Ex-Dividend Date |
Payment Date |
Type |
Amount |
Currency |
Total (Annual Dividends Per Share):
0.00p
Dividend Yield =
Annual Dividends Per Share (0.00p)
÷ Share Price (1224p)
= 0%
CVS Group Dividend History
| Ex Dividend Date |
Payment Date |
Type |
Amount |
Currency |
| 06/11/2025 |
05/12/2025 |
Final |
8.50p |
GBX |
| 31/10/2024 |
29/11/2024 |
Final |
8.00p |
GBX |
| 02/11/2023 |
08/12/2023 |
Final |
7.50p |
GBX |
| 17/11/2022 |
02/12/2022 |
Final |
7.00p |
GBX |
| 18/11/2021 |
03/12/2021 |
Final |
6.50p |
GBX |
| 21/11/2019 |
06/12/2019 |
Final |
5.50p |
GBX |
| 22/11/2018 |
07/12/2018 |
Final |
5.00p |
GBX |
| 23/11/2017 |
08/12/2017 |
Final |
4.50p |
GBX |
| 24/11/2016 |
09/12/2016 |
Final |
3.50p |
GBX |
| 26/11/2015 |
11/12/2015 |
Final |
3.00p |
GBX |
| 04/12/2014 |
22/12/2014 |
Final |
2.50p |
GBX |
| Year |
Final |
Currency |
Total |
Change |
| 2023 |
7.500 |
GBX |
7.500 |
7.140 |
| 2022 |
7.000 |
GBX |
7.000 |
7.690 |
| 2021 |
6.500 |
GBX |
6.500 |
18.180 |
| 2019 |
5.500 |
GBX |
5.500 |
10.000 |
| 2018 |
5.000 |
GBX |
5.000 |
11.110 |
| 2017 |
4.500 |
GBX |
4.500 |
28.570 |
| 2016 |
3.500 |
GBX |
3.500 |
16.660 |
| 2015 |
3.000 |
GBX |
3.000 |
20.000 |
| 2014 |
2.500 |
GBX |
2.500 |
|
CVS Group Dividend Calculator
CVS Group Dividend Growth
| Dividend Growth (1Y) |
6.25%
|
| Dividend CAGR (5Y) |
5.51%
|
| Years of Growth |
13
|
| Payout Ratio |
10.8%
|
| Buyback Yield |
-0.19%
|
| Shareholder Yield |
0.52%
|
| P/E Ratio (TTM) | 46.72 |
| Forward P/E | 13.82 |
| P/FCF | 15.68 |
| Earnings Yield | 6.04% |
| FCF Yield | 6.38% |
| ROE | 6.79% |
| ROCE | 8.69% |
| Profit Margin | 7.84% |
| Operating Margin | 7.4% |
| Gross Margin | 42.44% |